Drug manufacturing

Warwick Smith: ‘The pandemic has removed factors that allowed us to be resilient for Brexit’

The director general of the British Generic Manufacturers Association speaks about how manufacturers are planning to juggle Brexit with COVID-19, and what the government can do to help.…

Health bodies make ‘urgent’ call to Matt Hancock to intervene in the proposed withdrawal of bipolar drug

The health secretary, Matt Hancock, has been urged to “personally intervene” so that bipolar drug Priadel remains available in the UK with an appropriate pricing structure.…

Government in talks to offer drugs manufacturers incentives to diversify supply chains

The British Generic Manufacturers Association is in talks with the government over incentivising drugs firms to obtain active pharmaceutical ingredients from more than one source to avoid future supply problems.…

First-line treatment for bipolar disorder Priadel to be discontinued in UK from April 2021

The manufacturer of first-line bipolar disorder treatment Priadel is discontinuing production of the medicine, the Medicines and Healthcare products Regulatory Agency has announced…

Government asks medicines manufacturers to stockpile drugs for end of Brexit transition period

The government has asked drug manufacturers to rebuild six-week stockpiles of medicines in time for the UK’s transition period for leaving the EU ending on 31 December 2020.…

Manufacturer to move hydroxychloroquine production to the UK to avoid shortages

A manufacturer has announced plans to move production of hydroxychloroquine — currently being trialled as a COVID-19 treatment — to the UK from abroad to combat potential shortages.…

Manufacturers report ‘sporadic’ resupply of sertraline following COVID-19 related shortage

Supplies of the selective serotonin reuptake inhibitor, sertraline, are returning to stock after manufacturers reported “industry-wide” supply challenges, exacerbated by export bans and border closures implemented as a result of COVID-19. …

More than 70 new advanced therapy medicinal products could be available in the UK by 2024

As many as 72 new advanced therapy medicinal products could be available in the UK by 2024, according to horizon scanning by the NHS Specialist Pharmacy Service.…

Accord’s phenytoin sodium 100mg capsules out of stock until early May 2020

The pharmaceutical manufacturer Accord has said that its phenytoin sodium NRIM 100mg capsules, used for the management of epilepsy, will be out of stock until early May 2020.…

HRT products to return earlier than expected

Supplies of some hormone replacement therapies will be resupplied earlier than expected, following a decision to fast-track their manufacture.…